Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study
Titel:
Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study
Auteur:
Mizuta, Shuichi Sawa, Masashi Tsurumi, Hisashi Matsumoto, Kana Miyao, Kotaro Hara, Takeshi Takahashi, Takeshi Sakemura, Reona Kojima, Hiroshi Kohno, Akio Oba, Mari S. Morita, Satoshi Sakamoto, Junichi Emi, Nobuhiko